Effect of pre-existing malnutrition on growth parameters in HIV-infected children commencing antiretroviral therapy

Annals of Tropical Paediatrics

Volumn 28, Issue 4, 2008, Pages 279-285

  Bandyopadhyay, Anuja ^a,b   Bhattacharyya, S ^a  

^a MEDICAL COLLEGE AND HOSPITAL   (India)

^b NONE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; LAMIVUDINE PLUS NEVIRAPINE PLUS STAVUDINE;

AGE DISTRIBUTION; ARTICLE; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD GROWTH; CONTROLLED STUDY; FEMALE; GROWTH DISORDER; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFANT; MAJOR CLINICAL STUDY; MALE; MALNUTRITION; PROSPECTIVE STUDY; REFERENCE VALUE; SCORING SYSTEM; SEX DIFFERENCE; TUBERCULOSIS; WORLD HEALTH ORGANIZATION;

ANTHROPOMETRY; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BODY HEIGHT; BODY WEIGHT; CHILD; CHILD, PRESCHOOL; FEMALE; GROWTH; GROWTH DISORDERS; HIV INFECTIONS; HUMANS; INFANT; MALE; MALNUTRITION; PROSPECTIVE STUDIES;

EID: 59949098327     PISSN: 02724936     EISSN: None     Source Type: Journal    
DOI: 10.1179/146532808X375440     Document Type: Article

References (23)

1. Moye J, Rich KC, Kalish LA. Natural history of somatic growth in infants born to women infected by human immunodeficiency virus. J Pediatr 1996; 128:58-69.
2. Berhane R, Bagenda D, Marum L, et al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics 1997; 100:e7.
3. Merchant RH, Oswal JS, Bhagwat RV, Karkare J. Clinical profile of HIV infection. Indian Pediatr 2001; 38:239-46.
4. Schwenk A, Beisenherz A, Kremer G, Diehl V, Salzberger B, Fätkenheuer G. Bioelectrical impedance analysis in HIV-infected patients treated with triple antiretroviral treatment. Am J Clin Nutr 1999; 70:867-73.
5. Miller TL, Mawn BE, Orav EJ, et al. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics 2001; 107:e77.
6. Verweel G, van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics 2002; 109:e25.
7. Nadal D, Steiner F, Cheseaux JJ, Rudin C. Ritonavir promotes increased growth in HIV-infected children. Paediatric AIDS Group of Switzerland (letter). AIDS 1998; 12:2356-7.
8. Melvin AJ, Mohan KM, Arcuino LA, Edelstein RE, Frenkel LM. Clinical, virologic and immunologic responses of children with advanced human immunodeficiency virus type 1 disease treated with protease inhibitors. Pediatr Infect Dis J 1997; 16:968-74.
9. Dreimane D, Nielsen K, Deveikis A, Bryson YJ, Geffner ME. Effect of protease inhibitors combined with standard antiretroviral therapy on linear growth and weight gain in human immunodeficiency virus type 1-infected children. Pediatr Infect Dis J 2001; 20:315-16.
10. Ellis J, Molyneux EM. Experience of anti-retroviral treatment for HIV-infected children in Malawi: The 1st 12 months. Ann Trop Paediatr 2007; 27:261-7.
11. Johannessen A, Naman E, Ngowi BJ, et al. Predictors of mortality in HIV-infected patients starting antiretroviral therapy in a rural hospital in Tanzania. BMC Infect Dis 2008; 8:52.
12. Paton NI, Sangeetha S, Earnest A, Bellamy R. The impact of malnutrition on survival and the CD4 count response in HIV-infected patients starting antiretroviral therapy. HIV Med 2006; 7:323-30.
13. Kumar N, Shekhar C, Kumar P, Kundu AS. Kuppuswamy's socioeconomic status scale - updating for 2007. Indian J Pediatr 2007; 74:1131-2.
14. World Health Organization. Antiretroviral Therapy for HIV Infection in Infants and Children: Towards Universal Access. Geneva: WHO, 2006.
15. World Health Organization. The WHO Child Growth Standards. http://www.who.int/childgrowth/en/
16. Rousseau MC, Molines C, Moreau J, Delmont J. Influence of highly active antiretroviral therapy on micronutrient profiles in HIV-infected patients. Ann Nutr Metab 2000; 44:212-16.
17. Ndagije F, Baribwira C, Coulter JBS. Micronutrient and T-cell subsets: A comparison between HIV-infected and uninfected, severely malnourished Rwandan children. Ann Trop Paediatr 2007; 27:269-75.
18. Guarino A, Bruzzese E, De Marco G, Buccigrossi V. Management of gastrointestinal disorders in children with HIV infection. Paediatr Drugs 2004; 6:347-62.
19. Jones BM, Chiu SSS, Wong WHS, Lim WWL, Lau YL. Cytokine profiles in human immunodeficiency virus infected children treated with highly active antiretroviral therapy. Med Gen Med 2005; 7:71.
20. Gilden D. No attrition in research on wasting therapies. GMHC Treat Issues 1997; 11:9, 12-16.
21. Bobat R, Coovadia H, Moodley D, Coutsoudis A, Gouws E. Growth in early childhood in a cohort of children born to HIV-1-infected women from Durban, South Africa. Ann Trop Paediatr 2001; 21:203-10
22. Olinto MTA, Victora CG, Barros FC, Gigante DP. 24-hour recall overestimates the dietary intake of malnourished children. J Nutr 1994; 125:880-4.
23. World Health Organization. WHO Case Definitions Of HIV For Surveillance And Revised Clinical Staging And Immunological Classification Of HIV-Related Disease In Adults And Children. Geneva: WHO, 2006.